Frontiers in Surgery · 2021 · 19 citations · 32 references
MedicineOncologyRadiologyDiagnostic ImagingDiagnostic RadiologyThoracic RadiologyCancer DetectionComputed TomographyLung CancerOncologic Nuclear ImagingTumor CharacterizationTumor ImagingHistopathological SubtypesKi-67 ImagingKi-67 ImmunostainingLung AdenocarcinomaRadiology Image AnalysisRadiomic Feature ExtractionRadiomicsRadiomics In Lung Cancer
Purpose: The aims of this study were to combine CT images with Ki-67 expression to distinguish various subtypes of lung adenocarcinoma and to pre-operatively predict the Ki-67 expression level based on CT radiomic features. Methods: Data from 215 patients with 237 pathologically proven lung adenocarcinoma lesions who underwent CT and immunohistochemical Ki-67 from January 2019 to April 2021 were retrospectively analyzed. The receiver operating curve (ROC) identified the Ki-67 cut-off value for differentiating subtypes of lung adenocarcinoma. A chi-square test or t -test analyzed the differences in the CT images between the negative expression group ( n = 132) and the positive expression group ( n = 105), and then the risk factors affecting the expression level of Ki-67 were evaluated. Patients were randomly divided into a training dataset ( n = 165) and a validation dataset ( n = 72) in a ratio of 7:3. A total of 1,316 quantitative radiomic features were extracted from the Analysis Kinetics (A.K.) software. Radiomic feature selection and radiomic classifier were generated through a least absolute shrinkage and selection operator (LASSO) regression and logistic regression analysis model. The predictive capacity of the radiomic classifiers for the Ki-67 levels was investigated through the ROC curves in the training and testing groups. Results: The cut-off value of the Ki-67 to distinguish subtypes of lung adenocarcinoma was 5%. A comparison of clinical data and imaging features between the two groups showed that histopathological subtypes and air bronchograms could be used as risk factors to evaluate the expression of Ki-67 in lung adenocarcinoma ( p = 0.005, p = 0.045, respectively). Through radiomic feature selection, eight top-class features constructed the radiomic model to pre-operatively predict the expression of Ki-67, and the area under the ROC curves of the training group and the testing group were 0.871 and 0.8, respectively. Conclusion: Ki-67 expression level with a cut-off value of 5% could be used to differentiate non-invasive lung adenocarcinomas from invasive lung adenocarcinomas. It is feasible and reliable to pre-operatively predict the expression level of Ki-67 in lung adenocarcinomas based on CT radiomic features, as a non-invasive biomarker to predict the degree of malignant invasion of lung adenocarcinoma, and to evaluate the prognosis of the tumor.
32
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies, Paul E. Kinahan, Hedvig Hricak · Radiology · 2015 · 8.3K citations
Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 6.2K citations · Full text
Medicine, Biostatistics, Oncology +17
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
F. Davnall, Connie Yip, Gunnar Ljungqvist et al. · Insights into Imaging · 2012 · 878 citations · Full text
Translational Implications of Tumor Heterogeneity
Clinical Cancer Research · 2015 · 527 citations · Full text
Medicine, Cancer Biology, Oncology +17